Recent Articles
3 Stocks to Watch on Tuesday: Apple Inc. (AAPL), Verizon Communications Inc. (VZ) and Johnson & Johnson (JNJ)
Verizon (VZ) and Johnson & Johnson (JNJ) are dipping after their quarterly reports, while Apple (AAPL) suffers another downgrade.
Yahoo! Inc. (YHOO) Q4 Earnings: 10 Things to Know
Yahoo! Inc. (YHOO) posted its fiscal fourth-quarter results after the bell Monday. Here are 10 things you should know about the company's report.
Chinese Zodiac 2017: 12 Things to Know About the Year of the Rooster
The Chinese Zodiac dictates that, according to its 12-year cycle, 2017 will become the year of the rooster in less than five days. Here's what you should know.
Chinese New Year Zodiac for 2017
The Chinese New Year Zodiac for 2017 reveals that the new year will be celebrated in less than a week. Here's what you should know about it.
Star Wars VIII Title Revealed — ‘Star Wars: The Last Jedi’
Star Wars VIII will be the movie to come out immediately after the end of 'The Force Awakens.' The film's title has been revealed as 'The Last Jedi.'
Aetna Inc (AET) – Humana Inc (HUM) Merger Blocked by Judge
Aetna Inc's (AET) merger with Humana Inc (HUM) has been blocked by a federal judge. The proposed deal would've been worth $34 billion.
3 Stocks to Watch on Monday: AT&T Inc. (T), McDonald’s Corporation (MCD) and Tesla Motors Inc (TSLA)
AT&T (T) is losing cellphone subscribers, McDonald's (MCD) posts a Q4 beat and Tesla Motors (TSLA) provides an update about its future updates.
Starbucks Corporation (SBUX) Expands Parental Leave Benefits
Starbucks Corporation (SBUX) has expanded parental leave benefits, offering up to 18 weeks of paid leave to new mothers. What do you think?
Amazon.com, Inc. (AMZN) Adds Amazon ‘Dash’ Buttons to Homepage
Amazon.com, Inc. (AMZN) Dash buttons are being added to the e-commerce retailer's website. Here's what you should know about these.
Why Merck & Co., Inc. (MRK) Stock Is Higher Today
Merck & Co., Inc. (MRK) stock surged 3.6% Friday as the company is a step ahed of competitor Bristol-Myers in its lung cancer drug research.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.